Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite significant volatility, ...

BioNJ, New Jersey's life sciences trade association, announced today the successful launch of "Time Off for Clinical Trials" initiative, which encourages BioNJ member organizations to offer their ...

We live longer and longer, and as we age, a lot of us develop a series of health issues and chronic diseases, including ...

Some products have just become too expensive – and the prices aren't going down. Here are some buys that are no longer worth ...

A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry ...

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.